List of Excipients in API dorzolamide hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dorzolamide hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | BENZALKONIUM CHLORIDE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | HYDROXYETHYL CELLULOSE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | MANNITOL | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | SODIUM HYDROXIDE | |
| Merck Sharp & Dohme LLC | TRUSOPT | dorzolamide hydrochloride | 0006-3519 | TRISODIUM CITRATE DIHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dorzolamide hydrochloride
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Micro Labs Limited | dorzolamide hydrochloride | 42571-141 | BENZALKONIUM CHLORIDE |
| Micro Labs Limited | dorzolamide hydrochloride | 42571-141 | HYDROXYETHYL CELLULOSE |
| Micro Labs Limited | dorzolamide hydrochloride | 42571-141 | MANNITOL |
| Micro Labs Limited | dorzolamide hydrochloride | 42571-141 | SODIUM HYDROXIDE |
| Micro Labs Limited | dorzolamide hydrochloride | 42571-141 | TRISODIUM CITRATE DIHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dorzolamide hydrochloride
Excipient focus: BENZALKONIUM CHLORIDE
dorzolamide hydrochloride drug variants containing BENZALKONIUM CHLORIDE
dorzolamide hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: HYDROXYETHYL CELLULOSE
dorzolamide hydrochloride drug variants containing HYDROXYETHYL CELLULOSE
dorzolamide hydrochloride drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dorzolamide hydrochloride drug variants containing MANNITOL
dorzolamide hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
dorzolamide hydrochloride drug variants containing SODIUM CITRATE
dorzolamide hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
dorzolamide hydrochloride drug variants containing SODIUM HYDROXIDE
dorzolamide hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
dorzolamide hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
dorzolamide hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
dorzolamide hydrochloride drug variants containing WATER
dorzolamide hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
